Sort
48,018 grants matching “immunotherapy”
Neuroimmunology of Malignant Brain Tumors: Innate Mechanisms
$414,676Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2017 · NS
Neuroimmunology of Malignant Brain Tumors: Innate Mechanisms
$414,676Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2019 · NS
Structure-guided cancer immunotherapy design with HLA-Arena and CrossDome
$414,649Dinler Antunes · University Of Houston · R21 · FY2024 · CA
Adaptive Immune Regulation of Traumatic Injury
$414,636James A. Lederer · Brigham And Women'S Hospital · R01 · FY2024 · AI
Adaptive Immune Regulation of Traumatic Injury
$414,636James A. Lederer · Brigham And Women'S Hospital · R01 · FY2023 · AI
Adaptive Immune Regulation of Traumatic Injury
$414,636James A. Lederer · Brigham And Women'S Hospital · R01 · FY2020 · AI
Adaptive Immune Regulation of Traumatic Injury
$414,636James A. Lederer · Brigham And Women'S Hospital · R01 · FY2021 · AI
Adaptive Immune Regulation of Traumatic Injury
$414,636James A. Lederer · Brigham And Women'S Hospital · R01 · FY2022 · AI
B7 RECEPTORS, TUMOR IMMUNOTHERAPY AND IMMUNE REGULATION
$414,623Ohio State University · R01 · FY2003 · CA
Experimental Photoimmunotherapy of Ovarian Cancer
$414,551Massachusetts General Hospital · R01 · FY2005 · AR
Project 3. Overcoming Melanoma Treatment Resistance with Cytokine Immunotherapy
$414,525Aaron Michael Ring · Yale University · P50 · FY2024 · CA
Project 2. Harnessing Epigenetic Regulation of Endogenous Retroelements in Melanoma
$414,525Qin Yan · Yale University · P50 · FY2024 · CA
PROJECT 2: NF1-associated Glioblastoma
$414,508Luis F Parada · Indiana University Indianapolis · U54 · FY2022 · CA
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune Diabetes
$414,503Abdel Hamad · Johns Hopkins University · R01 · FY2016 · AI
LILRB modulates tumor microenvironment and promotes tumor progression
$414,496Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2022 · CA
Understanding functional roles and regulation of granzymes
$414,480Euna Yoo · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Therapeutic Vaccine for HIV/HPV-associated Oropharyngeal and Tonsillar Malignanci
$414,421Frank R. Jones · Etubics Corporation · R44 · FY2014 · DE
Adoptive Therapy of Ovarian Cancer with Autologous Genetically Modified T Cells
$414,354Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
ISG15 and Protein ISGylation in Cancer
$414,306Dong-Er Zhang · University Of California, San Diego · R01 · FY2021 · CA
Project 2: The Impact of Immunotherapy on Human Vaccination
$414,295E. John Wherry · Massachusetts General Hospital · U19 · FY2019 · AI
Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients
$414,249Philip Abbosh · Research Inst Of Fox Chase Can Ctr · U01 · FY2022 · CA
Solid-state nanopores and silicon nanomembranes for ultrasensitive protein biomarker detection
$414,227James L McGrath · University Of Rochester · R01 · FY2023 · EB
Personalizing immunotherapy in HER2+ breast cancer through quantitative imaging
$414,223Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2020 · CA
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
$414,188Yin Wang · University Of Maryland Baltimore · R01 · FY2021 · CA
How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatory T-regulatory cells
$414,148Fotini Gounari · University Of Chicago · R01 · FY2014 · AI